Tercica, Inc. - Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 20

Tercica, Inc. - Strategic SWOT Analysis Review

Summary

Tercica, Inc. (Tercica) is engaged in the development and commercialization of new therapeutics for the metabolic health and endocrine markets. Its major products consist of novel biologic products such as Increlex and Somatuline Depot. Its first product Increlex is developed for the treatment of children with short stature due to severe primary IGF-1 deficiency IGFD. Its second product Somatuline Depot is used for the long treatment of patients with acromegaly. The company is also engaged in the research and development of growth hormone/IGF-1 combination product candidates with Genentech, Inc. It is headquartered in California, the US. The company is acquired by Ipsen Group, an European drugmaking company in October 2008.

GlobalData’s Tercica, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

List of Tables
List of Figures
Section 1 - About the Company
Tercica, Inc. - Key Facts
Tercica, Inc. - Key Employees
Tercica, Inc. - Key Employee Biographies
Tercica, Inc. - Major Products and Services
Tercica, Inc. - History
Tercica, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Tercica, Inc. - Business Description
Tercica, Inc. - SWOT Analysis
SWOT Analysis - Overview
Tercica, Inc. - Strengths
Strength - Streamlining access to Increlex
Strength - Promising Product Candidates
Weakness - Lack of Manufacturing Facility
Opportunity - Acquisition by Ipsen
Opportunity - IGFD Market
Opportunity - Successful Clinical Trails
Threat - Tightening of the FDA’s Regulatory Oversight
Threat - Competitive Pressures-CRO
Threat - Pricing pressures
Tercica, Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Tercica, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Tercica, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Tercica, Inc., Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Tercica, Inc., Key Facts
Tercica, Inc., Key Employees
Tercica, Inc., Key Employee Biographies
Tercica, Inc., Major Products and Services
Tercica, Inc., History
Tercica, Inc., Key Competitors
Tercica, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Tercica, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Tercica, Inc., Recent Deals Summary

List of Figures
Tercica, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Tercica, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011

Pfizer Inc.
Eli Lilly and Company
Teva Pharmaceutical Industries Limited
QLT Inc.
Novo Nordisk A/S
Merck Serono International S.A
Genentech, Inc.
Cangene Corporation
Bristol-Myers Squibb Company
Ambrilia Biopharma Inc.

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• eBay - Strong Execution
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile